As ErbB2 knockdown can induce apoptotic tumor cell death (63,64), we used a siRNA against the ErbB2/HER2 tyrosine kinase in several human tumor cell lines expressing both HER2 and HER3. The gene discussed is ERBB3; the disease is neoplasm.